title: Food and Drug Administration Response to the ATTUD/SRNT Policy Statement on the Labeling of Nicotine Replacement Therapies.
authors.affiliation: Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
authors.forename: Celia
authors.initials: C
authors.lastname: Winchell
authors.affiliation: Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD ryan.raffaelli@fda.hhs.gov.
authors.forename: Ryan M
authors.initials: RM
authors.lastname: Raffaelli
authors.affiliation: Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
authors.forename: Rigoberto
authors.initials: R
authors.lastname: Roca
authors.affiliation: Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
authors.forename: Theresa
authors.initials: T
authors.lastname: Michele
mesh_terms: D006291:Health Policy; D009538:Nicotine / Q000008:administration & dosage*; D016540:Smoking Cessation / Q000379:methods*; D061485:Tobacco Use Cessation Devices / Q000592:standards*
chemical_list: D009538:Nicotine